Ma Kuang Healthcare Holding Limited (TPEX:4139)
Taiwan · Delayed Price · Currency is TWD 37.70
0.00 (0.00%)
Aug 18, 2026, 1:30 PM CST
TPEX:4139 Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,697 | 1,105 | 1,374 | 1,481 | 1,800 | 1,847 | |
Market Cap Growth | 39.33% | -19.60% | -7.18% | -17.73% | -2.54% | -26.57% |
Enterprise Value | 2,268 | 1,708 | 2,124 | 2,345 | 2,503 | 2,491 |
Last Close Price | 37.70 | 24.55 | 32.30 | 34.80 | 42.30 | 43.40 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 133.67 | - | - | 47.91 |
Forward PE | - | 44.35 | 44.35 | 44.35 | 44.35 | 44.35 |
PS Ratio | 1.57 | 1.01 | 1.22 | 1.22 | 1.70 | 1.93 |
PB Ratio | 3.75 | 2.32 | 2.71 | 3.16 | 3.69 | 3.49 |
P/TBV Ratio | 5.93 | 3.62 | 4.34 | 5.68 | 6.29 | 4.77 |
P/FCF Ratio | 7.88 | 5.17 | 4.38 | 9.09 | 37.47 | 9.63 |
P/OCF Ratio | 7.09 | 4.63 | 4.04 | 7.42 | 9.48 | 7.96 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.09 | 1.56 | 1.88 | 1.93 | 2.36 | 2.60 |
EV/EBITDA Ratio | 14.43 | 107.45 | 35.97 | 35.43 | 36.00 | 34.51 |
EV/EBIT Ratio | - | - | 141.63 | 94.62 | 65.88 | 54.58 |
EV/FCF Ratio | 10.53 | 7.99 | 6.77 | 14.39 | 52.11 | 12.99 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.40 | 1.44 | 1.40 | 1.88 | 1.70 | 1.23 |
Debt / EBITDA Ratio | 4.02 | 3.97 | 3.12 | 4.09 | 4.17 | 3.54 |
Debt / FCF Ratio | 2.94 | 3.21 | 2.27 | 5.41 | 17.25 | 3.40 |
Net Debt / Equity Ratio | 1.20 | 1.18 | 1.25 | 1.68 | 1.51 | 1.07 |
Net Debt / EBITDA Ratio | 291.27 | 35.27 | 10.79 | 11.93 | 10.60 | 7.84 |
Net Debt / FCF Ratio | 2.52 | 2.62 | 2.03 | 4.85 | 15.34 | 2.95 |
Asset Turnover | 0.78 | 0.78 | 0.76 | 0.78 | 0.73 | 0.69 |
Inventory Turnover | 20.45 | 21.43 | 21.19 | 13.69 | 9.40 | 10.37 |
Quick Ratio | 0.35 | 0.43 | 0.38 | 0.50 | 0.50 | 0.53 |
Current Ratio | 0.50 | 0.57 | 0.57 | 0.72 | 0.80 | 0.79 |
Return on Equity (ROE) | -19.61% | -16.39% | -0.21% | -8.28% | -6.98% | 7.00% |
Return on Assets (ROA) | -1.75% | -1.17% | 0.63% | 0.99% | 1.64% | 2.06% |
Return on Invested Capital (ROIC) | -3.86% | -2.40% | -0.12% | 2.00% | 3.28% | 3.00% |
Return on Capital Employed (ROCE) | -5.60% | -3.40% | 1.80% | 2.60% | 3.90% | 5.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -4.66% | -6.07% | 0.75% | -2.87% | -1.72% | 2.09% |
FCF Yield | 12.69% | 19.35% | 22.81% | 11.00% | 2.67% | 10.38% |
Payout Ratio | - | - | - | - | - | 176.64% |
Buyback Yield / Dilution | -3.09% | -1.65% | - | - | 0.10% | 0.03% |
Total Shareholder Return | -3.09% | -1.65% | - | - | 0.10% | 0.03% |